Markowitz JS, Straughn AB, Patrick KS, DeVane CL, Pestreich L, Lee J, Wang Y, Muniz R
journal
Clin Pharmacokinet
Date Published
2003;42(4):393-401
Why link to a visual abstract?
What is a visual abstract?
Visual
Original
Study Summary
π¬
What They Studied
They studied how quickly and how much of two modified-release formulations of methylphenidate are absorbed in the body.
π‘
What They Found
The study found that Ritalin LA is absorbed more quickly and reaches a higher peak in the bloodstream compared to Concerta, although the overall absorption was similar.
π
What This Means
The findings indicate that Ritalin LA has a quicker onset and higher peak plasma concentration compared to Concerta, which is consistent with guidelines that mention different pharmacokinetic profiles for ADHD medications like these.
Study Summary
Study Overview
This study aimed to compare two ADHD medications, Ritalin LA and Concerta, to find out how their different absorption rates affect treatment. It focused on how quickly symptoms could be controlled during the day when attention is critical.
Findings showed that Ritalin LA's unique absorption pattern may offer advantages, potentially leading to quicker symptom relief and better support for patients who manage ADHD in active daily settings.
Abstract: background
To compare the rate and extent of absorption of DL-threo-methylphenidate (MPH) from two modified-release MPH formulations at their respective recommended starting doses in healthy adult volunteers.
Biphasic Profile Impact
"The distinctly biphasic pharmacokinetic profile observed with Ritalin LA, compared to the more plateau-like profile of Concerta, suggests differing impacts on absorption dynamics that may influence therapeutic outcomes."
Initial Absorption Advantage
"The study highlights the potential advantage of Ritalin LAβs rapid initial absorption, which might correspond with the periods where ADHD symptoms require the most management, such as during school hours."
Tailored Treatment Strategies
"The distinct MPH plasma concentration profiles achieved by each formulation may have implications for treatment strategies, suggesting tailored formulation choice based on individual patient needs."
Study Summary
Methods
Participants in the study took single doses of two extended-release forms of methylphenidate: a 20mg capsule (Ritalin LA) and an 18mg tablet (Concerta). Over a 24-hour period, 19 blood samples were collected from each participant. These samples were analyzed to determine how much of the medication entered the bloodstream.
The study used sophisticated lab techniques to measure related pharmacological parameters, comparing the two formulations based on their bioavailability and how efficiently the drug entered the bloodstream.
Abstract: methods
Subjects received single doses of two modified-release formulations of MPH, a 20mg capsule (Ritalin) LA) and an 18 mg tablet (Concerta). A total of 19 plasma samples was collected over 24 hours, and MPH plasma concentrations were determined by liquid...more
Study Summary
Results
The study included 19 participants, both male and female, aged between 21 and 34 years. The Ritalin LA capsule showed a unique absorption pattern with two distinct peaks in the bloodstream. This means the drug level rose significantly soon after taking and peaked again a few hours later. Concerta's absorption was slower but steadier.
Ritalin LA absorbed more quickly in the first few hours but overall, the total absorption and clearance in the body were similar for both medications over the full period examined. This suggests that both forms deliver the drug similarly in the long run, despite initial differences in speed and concentration.
Abstract: results
Nineteen subjects, ten male and nine female, aged 21-34 years completed both treatment phases of the study. The Ritalin LA formulation displayed a distinctly biphasic pharmacokinetic profile, with mean initial peak plasma concentration of 7 microg/L ...more
Study Summary
Conclusions
Ritalin LA showed faster initial absorption and achieved higher concentrations in the blood than Concerta. Despite this, the total bioavailability was comparable for both formulations. The unique absorption pattern for Ritalin LA means it rises and falls twice distinctly.
These findings suggest that, at starting doses, Ritalin LA may offer quicker relief of symptoms due to its initial rapid absorption and higher concentrations compared to Concerta, which provided a steadier release over a longer period.
Abstract: conclusions
The Ritalin LA formulation exhibited more rapid initial absorption and reached significantly higher peak plasma concentrations compared with the Concerta formulation, although the oral bioavailability of MPH was similar between the two formulations. ...more
Background Information
Patient Guide
π§
Mechanism of Methylphenidate
Increases norepinephrine and dopamine levels by blocking their reuptake, enhancing synaptic concentration.
π§¬
Methylphenidate Metabolism
Primarily metabolized in the liver to ritalinic acid through de-esterification.
π
Methylphenidate Formulations
Available in immediate, extended, and sustained-release forms to meet patient needs.
π
Methylphenidate Dosing
Doses require careful management with a max daily dose of 72 mg for extended-release tablets.
Professional Guide
Expert Opinion: Pharmacokinetics of methylphenidate in healthy adults
In light of the abstract findings, understanding cardiovascular screening is crucial for those considering Ritalin to address cardiac risks.
Methylphenidate requires attention to cardiovascular screening due to the modest increase in heart rate and blood pressure.
Stimulant medications like Ritalin can have immediate clinical effects, making them a prominent choice in managing ADHD symptoms in adults.
Evidence Summary
How Ritalin Travels from Stomach to Brain
Ritalin, commonly used to help manage mental health symptoms, starts its journey in your stomach. After you swallow it, the medication gets absorbed into the bloodstream, traveling through your body until it reaches your brain.
Once there, Ritalin acts to regulate brain activity, targeting specific symptoms. This pathway highlights how Ritalin moves through your system to deliver its effects where they're needed most.
Evidence Summary
Timing Ritalinβs Peak Effect for Best Results
Ritalin generally reaches its peak effect between 1 to 2 hours after taking it, though this timing can vary based on personal factors, such as metabolism.
Doctors may fine-tune doses to help individuals experience Ritalinβs effects at the most beneficial time for their needs, adjusting as necessary to find the right balance for each person.
Evidence Summary
Monitoring Heart Health with ADHD Medications
Concerta and Ritalin, two commonly prescribed ADHD medications, can impact heart rate and blood pressure. Patients taking these drugs need regular check-ups to track any cardiovascular changes.
Doctors monitoring patients on these treatments can help manage any potential effects on blood pressure, ensuring safe, effective treatment.
This helps align with research on how these medications might influence cardiovascular functions.